Alpha Teknova, Inc. Share Price & Technical Analysis
TKNO · $4.63 (+3.81%)
Healthcare / Drug Manufacturers - Specialty & Generic
$4.63
+3.81%
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for samp…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-17% return in Jun, -22% avg return in past 3 year Jun month.
50% return in 2026, 62% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -37% | 8% | 16% | 21% | 59% | -17% | – | – | – | – | – | – | 50% |
| 25 | 7% | -23% | -22% | 26% | -12% | -14% | -8% | -2% | 48% | -15% | -10% | -21% | -45% |
| 24 | -14% | -9% | -10% | -31% | 0% | -22% | 171% | 29% | -2% | 39% | 9% | 12% | 172% |
| 23 | 7% | -10% | -44% | -41% | 100% | -29% | 26% | -41% | 40% | -26% | 0% | 76% | 58% |
| 22 | -24% | 7% | -18% | -18% | -32% | 9% | -23% | -30% | -27% | 35% | 2% | 17% | -101% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Uptrend
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$250.65M
P/E ratio
—
52W high
$6.68
52W low
$1.91
Volume
15,165
Beta
0.63
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Alpha Teknova, Inc. share price today?
- Alpha Teknova, Inc. (TKNO) last traded around $4.63 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TKNO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TKNO. Download the app for real-time alerts.
- How can I analyze Alpha Teknova, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.